通过智能手机高频远程监测帕金森病:平台概述和药物反应检测
High Frequency Remote Monitoring of Parkinson's Disease via Smartphone: Platform Overview and Medication Response Detection
摘要:
目的:本研究的目的是开发一种基于智能手机的高频远程监测平台,评估其用于帕金森病症状远程监测的可行性,并通过检测多巴胺能药物反应来证明使用该平台收集的数据的价值。研究方法:我们开发了HopkinsPD,一种新型的基于智能手机的监测平台,它可以主动测量症状(即当个人在一天中的特定时间启动一套测试时收集数据),也可以被动测量症状(即在后台连续收集数据)。在数据汇集之后,我们提取特征来评估与PD症状相关的五个关键行为的测量-声音,平衡,步态,灵巧性和反应时间。使用随机森林分类器来区分在药物剂量(治疗)之后与在药物剂量(基线)之前进行的测量。结果:2014年7月,使用HopkinsPD建立了一项全球远程PD监测研究。这项研究完全使用远程在线招聘和安装,展示了高度经济有效的可扩展性。在六个月内,226人(121名PD和105名对照)提供了超过46,000小时的被动监测数据和大约8,000例声音,平衡,步态,反应和灵活性的结构化测试。据我们所知,这是第一项以如此规模收集数据进行远程PD监测的研究。此外,我们证明了从基线区分治疗的初始能力,准确率为71.0(+-0.4)%,这表明可以通过基于智能手机的措施远程监测药物反应。
英文摘要:
Objective: The aim of this study is to develop a smartphone-based high-frequency remote monitoring platform, assess its feasibility for remote monitoring of symptoms in Parkinson's disease, and demonstrate the value of data collected using the platform by detecting dopaminergic medication response. Methods: We have developed HopkinsPD, a novel smartphone-based monitoring platform, which measures symptoms actively (i.e. data are collected when a suite of tests is initiated by the individual at specific times during the day), and passively (i.e. data are collected continuously in the background). After data collection, we extract features to assess measures of five key behaviors related to PD symptoms -- voice, balance, gait, dexterity, and reaction time. A random forest classifier is used to discriminate measurements taken after a dose of medication (treatment) versus before the medication dose (baseline). Results: A worldwide study for remote PD monitoring was established using HopkinsPD in July, 2014. This study used entirely remote, online recruitment and installation, demonstrating highly cost-effective scalability. In six months, 226 individuals (121 PD and 105 controls) contributed over 46,000 hours of passive monitoring data and approximately 8,000 instances of structured tests of voice, balance, gait, reaction, and dexterity. To the best of our knowledge, this is the first study to have collected data at such a scale for remote PD monitoring. Moreover, we demonstrate the initial ability to discriminate treatment from baseline with 71.0(+-0.4)% accuracy, which suggests medication response can be monitored remotely via smartphone-based measures.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。